Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
BMC Med Genet. 2020 Jun 30;21(1):140. doi: 10.1186/s12881-020-01075-1.
Cohen syndrome, an autosomal recessive syndrome, is a rare syndrome with diverse clinical manifestations including failure to thrive, hypotonia, hypermobile joints, microcephaly, intellectual disabilities, craniofacial and limb anomalies, neutropenia and a friendly character. It is associated with mutations of the vacuolar protein sorting 13 homolog B (VPS13B) gene, which is involved in the development of the ocular, hematological and central nervous systems. This gene encodes a transmembrane protein playing a crucial role in preserving the integrity of the Golgi complex. To date, more than 150 mutations of VPS13B have been reported in over 200 Cohen syndrome patients. Missense or nonsense mutations are the most common mutations.
A 4-year-old girl, born to consanguineous parents, was referred to the pediatric clinical immunology outpatient clinic for investigation of recurrent neutropenia with a history of recurrent infections in the past year. On physical examination, she had the characteristic facial features of Cohen syndrome, developmental delay and speech disorder. She had a cheerful disposition, and her mother gave a history of feeding difficulties in her first months of life. She did not present any ophthalmologic or cardiac abnormalities. Her lab results revealed moderate neutropenia. Serum IgG, IgM, IgA and IgE levels were normal. She fulfilled the clinical diagnostic criteria for Cohen syndrome. WES revealed a novel homozygous frameshift variant in VPS13B (LRG_351t1: c.7095del; p.Ser2366AlafsTer49). Currently, she is not experiencing any severe problem, and she undergoes irregular medical treatment once her neutrophil count decreases under the normal limit. Her verbal and motor abilities have improved as a result of speech and occupational therapies.
We reported a novel homozygous frameshift variant in VPS13B (LRG_351t1: c.7095del; p.Ser2366AlafsTer49) in a 4-year-old girl with Cohen syndrome. Cohen syndrome should be considered in differential diagnosis of any child with intellectual disability and neutropenia.
Cohen 综合征是一种常染色体隐性遗传综合征,是一种罕见的综合征,具有多种临床表现,包括生长不良、张力减退、关节活动过度、小头畸形、智力障碍、颅面和肢体异常、中性粒细胞减少和性格友善。它与液泡蛋白分选 13 同源物 B(VPS13B)基因突变有关,该基因突变参与了眼、血液和中枢神经系统的发育。该基因编码一种跨膜蛋白,在维持高尔基体复合体的完整性方面发挥着关键作用。迄今为止,已有超过 200 名 Cohen 综合征患者报告了超过 150 种 VPS13B 基因突变。错义或无义突变是最常见的突变。
一名 4 岁女孩,出生于近亲父母,因反复中性粒细胞减少症和过去一年反复感染的病史,被转至儿科临床免疫学门诊就诊。体格检查显示她具有 Cohen 综合征的特征性面部特征、发育迟缓、言语障碍。她性格开朗,母亲说她在生命的头几个月有喂养困难。她没有出现任何眼科或心脏异常。她的实验室结果显示中度中性粒细胞减少症。血清 IgG、IgM、IgA 和 IgE 水平正常。她符合 Cohen 综合征的临床诊断标准。WES 发现 VPS13B 中的一个新的纯合框移突变(LRG_351t1:c.7095del;p.Ser2366AlafsTer49)。目前,她没有出现任何严重问题,当她的中性粒细胞计数低于正常范围时,她会进行不规则的治疗。由于言语和职业治疗,她的言语和运动能力有所提高。
我们报道了一名 4 岁女孩 Cohen 综合征中 VPS13B 的一个新的纯合框移突变(LRG_351t1:c.7095del;p.Ser2366AlafsTer49)。在任何有智力障碍和中性粒细胞减少症的儿童中,都应考虑 Cohen 综合征的鉴别诊断。